CAPLIPOINT — Caplin Point Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Caplin Point Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12,694	14,667	16,941	19,375	21,872
Cost of Revenue
Gross Profit	6,876	7,719	9,312	11,217	13,215
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	9,213	10,700	11,952	13,526	14,991
Operating Profit	3,481	3,968	4,989	5,849	6,881
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,858	4,514	5,644	6,768	8,028
Provision for Income Taxes
Net Income After Taxes	3,085	3,770	4,614	5,411	6,497
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,998	3,763	4,571	5,363	6,412
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,998	3,763	4,571	5,363	6,412
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	39.2	49.2	60	70.6	84.1
Dividends per Share